Displaying 1 - 1 of 1
| Active Ingredient | GLICLAZIDE |
| Therapeutic Class | SULPHONYLUREAS |
| Indications | Treatment of diabetes mellitus. May be of benefit in retinopathy. |
| Caution | Gastro intestinal upset, nausea, hypoglycemia, weight gain, dizziness. c.f. prescribing in liver and renal disease p. 14; 30. |
| Dose Range |
Intial dose: 40- 80 mg daily with breakfast, gradually increasing to 320 mg daily . Doses of more than 160 mg daily are given in 2 divided doses. M odified-release: initial dose is 30 mg once daily , increasing if necessary in step s of |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |